Skip to main content

and
  1. Article

    Open Access

    Correction to: Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial

    The article ‘‘Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial’’, written by Mark A. Moyad, Larry E. Robinso...

    Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud in Advances in Therapy (2019)

  2. Article

    Open Access

    Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial

    Allergic rhinitis (AR) impacts around 25% of the worldwide population. However, cost, safety, and a high dissatisfaction rate with numerous conventional medications continues to be an issue in the largest pati...

    Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud in Advances in Therapy (2009)